InvestorsHub Logo
Followers 7
Posts 369
Boards Moderated 1
Alias Born 08/27/2003

Re: None

Wednesday, 07/12/2006 11:13:43 AM

Wednesday, July 12, 2006 11:13:43 AM

Post# of 1035
EVSC...the cheapest advanced stage biotech in the world!

I am back.

I traded Endovasc quite a bit back in 2002, 2003 (ENDV) and have left the stock alone since then because of significant dilution and management problems.

But I think it is time to start acquiring the stock (in small amounts) for the posibility that the new management is on the right track to getting Liprostin into phaseIII clinical trials soon. Furthermore the trial protocol is designed for the trials to be a very short period of time (initial review at 6 weeks), so penny-biotech investors/traders are going to be flocking here in droves if (when) Liprostin actually heads into trials (IMO).

I personally own a meager 50,000 shares at .033 and control another 100,000 for other people at .03.

The three cent range is my target for entry as it seems the stock has bottomed out here and insiders have exercised a decent portion of options at 3 cents:

http://finance.yahoo.com/q/it?s=EVSC.OB

Cheers!

Timing



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.